{"pub": "telegraph", "url": "https://telegraph.co.uk/business/2019/10/13/neil-woodfords-plan-float-oxford-nanopore-looks-increasingly", "downloaded_at": "2019-10-13 08:53:06.998565+00:00", "title": "Neil Woodford\u2019s plan to float Oxford Nanopore looks \u2018increasingly like a daydream\u2019", "language": "en", "text": "Neil Woodford\u2019s route to exit one of his largest unlisted holdings, either through a float or as part of a private debt raising fundraising, is looking increasingly unlikely, according to City sources.\n\nLife sciences company Oxford Nanopore will struggle to pursue a public listing or fundraising before the end of the year due to a sluggish IPO market and growing concern around private companies going public too soon, sources said.\n\nA listing would have raised some much needed cash for the embattled fund manager, who is facing a liquidity crisis at his still-gated equity income fund and a debt deadline over at sister vehicle Woodford Patient Capital Trust.\n\nIn April, prior to the gating of his flagship...", "description": "Neil Woodford\u2019s route to exit one of his largest unlisted holdings, either through a float or as part of a private debt raising fundraising, is looking increasingly unlikely, according to City sources.", "authors": ["Harriet Russell", "Jeremy Warner", "Liam Halligan", "Matthew Lynn", "Russell Lynch", "Andy Critchlow", "Ben Marlow"], "top_image": "https://www.telegraph.co.uk/content/dam/business/2019/09/30/TELEMMGLPICT000030618798-xlarge_trans_NvBQzQNjv4BqpVlberWd9EgFPZtcLiMQfyf2A9a6I9YchsjMeADBa08.jpeg?imwidth=1200", "published_at": "2019-10-13"}